{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:20:34Z","timestamp":1760548834239},"reference-count":7,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.ijantimicag.2009.06.001","type":"journal-article","created":{"date-parts":[[2009,7,11]],"date-time":"2009-07-11T08:46:57Z","timestamp":1247302017000},"page":"386-388","source":"Crossref","is-referenced-by-count":16,"title":["High imipenem blood concentrations associated with toxic encephalopathy in a patient with mild renal dysfunction"],"prefix":"10.1016","volume":"34","author":[{"given":"Fr\u00e9d\u00e9ric","family":"Lamoth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Erard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Asner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Buclin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Calandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2009.06.001_bib1","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0002-9343(88)90071-X","article-title":"Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem\/cilastatin","volume":"84","author":"Calandra","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2009.06.001_bib2","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/ndt\/13.7.1896","article-title":"Neurological complication during imipenem\/cilastatin therapy in uraemic patients","volume":"13","author":"Campise","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ijantimicag.2009.06.001_bib3","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S1473-3099(08)70228-7","article-title":"Pharmacodynamics and pharmacokinetics of antibacterial drugs in the management of febrile neutropenia","volume":"8","author":"Lortholary","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.06.001_bib4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1128\/AAC.00891-08","article-title":"Reassessment of recommended imipenem doses in febrile neutropenic patients with hematological malignancies","volume":"53","author":"Lamoth","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.06.001_bib5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijantimicag.2005.09.016","article-title":"Trough serum concentrations of \u03b2-lactam antibiotics in cancer patients: inappropriateness of conventional schedules to pharmacokinetic\/pharmacodynamic properties of \u03b2-lactams","volume":"27","author":"Navas","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2009.06.001_bib6","unstructured":"National Cancer Institute. Common terminology criteria for adverse events (CTCAE) v4.0. National Cancer Institute; 2009. http:\/\/ctep.cancer.gov\/reporting\/ctc.html [accessed 5 June 2009]."},{"key":"10.1016\/j.ijantimicag.2009.06.001_bib7","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.2042-7158.1995.tb05798.x","article-title":"Comparative convulsant potencies of two carbapenem derivatives in C57 and DBA\/2 mice","volume":"47","author":"de Sarro","year":"1995","journal-title":"J Pharm Pharmacol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857909002866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857909002866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T12:27:38Z","timestamp":1545136058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857909002866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0924857909002866"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2009.06.001","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}